Abstract
Alzheimer type II astrocytosis is the pathological hallmark of hepatic encephalopathy. These astrocytes undergo a characteristic morphological change and, in addition, lose immunoreactivity for glial fibrillary acidic protein (GFAP). However, a previous study in the portacaval shunted rat, a model of hepatic encephalopathy, revealed increased rather than decreased GFAP immunoreactivity in Bergmann glia, a specialized group of cerebellar astrocytes. In the present study, sections of cerebellar vermis from 15 cirrhotic patients with hepatic encephalopathy and varying degrees of Alzheimer type II astrocytosis were stained using antisera to GFAP. The Bergmann glial cells did not show altered GFAP immunoreactivity compared to controls. In addition, the degree of GFAP immunoreactivity was not correlated with the degree of Alzheimer type II change nor related to the aetiology of the liver disease. These results suggest a differential response of Bergmann glia in human hepatic encephalopathy.
Similar content being viewed by others
References
Butterworth R. F. (1993) Portal-systemic encephalopathy: A disorder of neuron-astrocytic metabolic trafficking.Develop. Neurosci. 15, 313–319.
Butterworth R. F. (1995) Hepatic encephalopathy.The Neurologist 1, 95–104.
Cavanagh J. B. and Kyu M. H. (1971) Type II Alzheimer change experimentally produced in astrocytes in the rat.J. Neurol. Sci. 12, 63–75.
Cavanagh J. B., Lewis P. D., Blakemore W. F., and Kyu M. (1972) Changes in the cerebellar cortex in rats after portacaval anastomosis.J. Neurol. Sci. 15, 13–26.
Diemer N. H., Klee J., Schroder H., and Klinken L. (1977) Glial and nerve cell changes in rats with porto-caval anastomosis.Acta Neuropathol. 39, 59–68.
Duchen L. W. and Jacobs J. M. (1992) Nutritional deficiencies and metabolic disorders, inGreenfield's Neuropathology (Adams, J. H. and Duchen, L. W., eds.), pp. 811–880, Edward Arnold, London, UK.
Eng L. F. (1985) Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes.J. Neuroimmunol. 8, 203–214.
Halliday G. M., Cullen K. M., Kril J. J., Harding A. J., and Harasty J. (1996) Glial fibrillary acidic protein (GFAP) immunohistochemistry in the human cortex: a quantitative study using different antisera.Neurosci. Lett. 209, 29–32.
Kimura T. and Budka H. (1987) Glial fibrillary acidic protein and S-100 protein in human hepatic encephalopathy: Immunocytochemical demonstration of dissociation of two glia-associated proteins.Acta Neuropathol. 70, 17–21.
Kril J. J. (1996) The neuropathology of thiamine deficiency disorders.Metab. Brain Dis. 11, 9–17.
Neary J. T., Whittemore S. R., Zhu Q. and Norenberg M. D. (1994) Destabilization of glial fibrillary acidic protein mRNA in astrocytes by ammonia and protection by extracellular ATP.J. Neurochem. 63, 2021–2027.
Norenberg M. D. (1987) The role of astrocytes in hepatic encephalopathy.Neurochem. Pathol. 6, 13–33.
Norenberg M. D. (1994) Astrocyte responses to CNS injury.J. Neuropathol. Exp. Neurol. 53, 213–220.
Norenberg M. D., Neary J. T., Luz-Oliva B., and McCarthy M. (1990) Ammonia induced decrease in glial fibrillary acidic protein in cultured astrocytes.J. Neuropathol. Exp. Neurol. 49, 399–405.
Phillips S. C., Harper C. G., and Kril J. J. (1987) A quantitative histological study of the cerebellar vermis in alcoholic patients.Brain 110, 301–314.
Phillips S. C., Harper C. G., and Kril J. J. (1990) The contribution of Wernicke's encephalopathy to alcohol-related cerebellar damage.Austral. Drug Alcohol Rev. 9, 53–60.
Pilbeam C. M., Anderson M. D., and Bathal P. S. (1983) The brain in experimental portal systemic encephalopathy. I Morphological changes in three animal models.J. Pathol. 140, 331–345.
Raghavendra Rao V. L. and Butterworth R. F. (1995) Thiamine phosphatases in human brain: Regional alterations in patients with alcoholic cirrhosis.Alcohol Clin. Exp. Res. 19, 523–526.
Sobel R. A., DeArmond S. J., Forno L. S., and Eng L. F. (1981) Glial fibrillary acidic protein in hepatic encephalopathy. An immunohistochemical study.J. Neuropathol. Exp. Neurol. 40, 625–632.
Suarez L., Bodega G., Arilla E., Villalba R., and Fernandez B. (1991) Differential response of astrocytes and Bergmann glial cells to portacaval shunt: An immunohistochemical study in the rat cerebellum.Glia 6, 172–179.
Victor M., Adams R. D., and Collins G. H. (1989)The Wernicke-Korsakoff Syndrome, 2nd ed., F. A. Davis Company, Philadelphia, PA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kril, J.J., Flowers, D. & Butterworth, R.F. Distinctive pattern of Bergmann glial pathology in human hepatic encephalopathy. Molecular and Chemical Neuropathology 31, 279–287 (1997). https://doi.org/10.1007/BF02815130
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02815130